Glen Kurokawa

Learn More
There are acute disparities in pharmaceutical access between developing and industrialized countries. Developing countries make up approximately 80% of the world's population but only represent approximately 20% of global pharmaceutical consumption. Among the many barriers to drug access are the potential consequences of the Trade Related Aspects of(More)
The designations employed and the presentation of material throughout this publication do not imply the expression of any opinion whatsoever on the part of any organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The authors are responsible for(More)
  • 1